KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Enterprise Value (2016 - 2025)

Eli Lilly (LLY) has disclosed Enterprise Value for 17 consecutive years, with -$7.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value fell 117.39% year-over-year to -$7.3 billion, compared with a TTM value of -$7.3 billion through Dec 2025, down 117.39%, and an annual FY2025 reading of -$7.3 billion, down 117.39% over the prior year.
  • Enterprise Value was -$7.3 billion for Q4 2025 at Eli Lilly, up from -$9.9 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at -$2.1 billion in Q4 2022 and bottomed at -$9.9 billion in Q3 2025.
  • Average Enterprise Value over 5 years is -$3.5 billion, with a median of -$3.1 billion recorded in 2021.
  • The sharpest move saw Enterprise Value surged 44.11% in 2022, then plummeted 186.7% in 2025.
  • Year by year, Enterprise Value stood at -$3.7 billion in 2021, then soared by 44.11% to -$2.1 billion in 2022, then tumbled by 35.94% to -$2.8 billion in 2023, then dropped by 17.89% to -$3.3 billion in 2024, then crashed by 117.39% to -$7.3 billion in 2025.
  • Business Quant data shows Enterprise Value for LLY at -$7.3 billion in Q4 2025, -$9.9 billion in Q3 2025, and -$3.5 billion in Q2 2025.